TIANFU CHEM Carbidopa

Min.Order / FOB Price:Get Latest Price

1 Kilogram	Negotiable

1 Kilogram

Negotiable

Min.Order :1 Kilogram
Purity: 99%
Payment Terms : L/C,D/A,D/P,T/T,,MoneyGram

Keywords

Carbidopa 38821-49-7 TIANFU CHEM Carbidopa

Quick Details

Appearance:Solid
Application:Intermediates
PackAge:as requested
ProductionCapacity:1|Metric Ton|Month
Storage:room temperature
Transportation:by sea, by air or by courier

Superiority:

Our company was built in 2009 with an ISO certificate.

In the past 5 years, we have grown up as a famous fine chemicals supplier in China and we had established stable business relationships with Samsung,LG,Merck,Thermo Fisher Scientific and so on.

Our main business covers the fields below:

1.Noble Metal Catalysts (Pt.Pd...)

2.Organic Phosphine Ligands (Tert-butyl-phosphine.Cyclohexyl-phosphine...)

3.OLED intermediates (Fluorene,Carbazole,Boric acid...)

4.Customs Synthesis

Our advantage:

1.Higest quality and good package

2.Fast delivery

3.Better payment term

4.Fast response to customer within 6 hours

5.Good business credit in Europe ,US ,Japan ,Korea

Details:

Product Name: Carbidopa
Synonyms: (-)-l-alpha-hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamicacidmonohydrat;(-)-l-alpha-hydrazino-3,4-dihydroxy-alpha-methyl-hydrocinnamicacimonohydr;alpha-hydrazino-3,4-dihydroxy-alpha-methyl-benzenepropanoicacimonohydra;lodosyn;CARBIDOPA;CARBIDOPA HYDRATE;CARBIDOPA MONOHYDRATE;(S)-(-)-CARBIDOPA MONOHYDRATE
CAS: 38821-49-7
MF: C10H16N2O5
MW: 244.24
EINECS:
Product Categories: Other APIs;Pharmaceutical intermediates;Inhibitors
Mol File: 38821-49-7.mol
Carbidopa Structure
Carbidopa Chemical Properties
CAS DataBase Reference 38821-49-7(CAS DataBase Reference)
Safety Information
RTECS MW5300000
HazardClass IRRITANT
MSDS Information
Carbidopa Usage And Synthesis
Definition ChEBI: The hydrate of 3-(3,4-dihydroxyphenyl)propanoic acid in which the hydrogens alpha- to the carboxyl group are substituted by hydrazinyl and methyl groups (S-configuration). Carbidopa is a dopa decarboxylase inhibitor, so pr vents conversion of levodopa to dopamine. It has no antiparkinson activity by itself, but is used in the management of Parkinson's disease to reduce peripheral adverse effects of levodopa.

View All

Visit Store